Expleo Solutions (NSE:EXPLEOSOL) 1-Year Sharpe Ratio: -1.03 (As of Jul. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:EXPLEOSOL Expleo Solutions Ltd NSE:EXPLEOSOL
87 GF Score
Price ₹792.40
GF Value ₹1,289.11
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Expleo Solutions 1-Year Sharpe Ratio?

Expleo Solutions NSE:EXPLEOSOL -0.79% 87 1-Year Sharpe Ratio is -1.03 as of Jul. 19, 2026. GuruFocus rates NSE:EXPLEOSOL with a GF Score™ of 87/100 and a GF Value™ of ₹1,289.11 (Significantly Undervalued). The stock has 3 warning signs investors should review.

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-07-19), Expleo Solutions's 1-Year Sharpe Ratio is -1.03.

Expleo Solutions  (NSE:EXPLEOSOL) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

Expleo Solutions 1-Year Sharpe Ratio Related Terms

NSE:EXPLEOSOL vs IBM, ACN, FISV: 1-Year Sharpe Ratio Comparison

For the Information Technology Services subindustry, Expleo Solutions's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Expleo Solutions 1-Year Sharpe Ratio vs Software Industry

For the Software industry and Technology sector, Expleo Solutions's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Expleo Solutions's 1-Year Sharpe Ratio falls into.


NSE:EXPLEOSOL
87GF Score
Expleo Solutions Ltd NSE:EXPLEOSOL
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Expleo Solutions 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of -1.03 mean?
Expleo Solutions (NSE:EXPLEOSOL) has a 1-Year Sharpe Ratio of -1.03 as of Jul. 19, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Expleo Solutions and its competitors.
Is Expleo Solutions' 1-Year Sharpe Ratio too high?
Expleo Solutions' current 1-Year Sharpe Ratio is -1.03. Overall, Expleo Solutions has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Expleo Solutions' 1-Year Sharpe Ratio compare to IBM and ACN?
Expleo Solutions' 1-Year Sharpe Ratio of -1.03 can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Software company?
A good 1-Year Sharpe Ratio depends on the Software industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Expleo Solutions and its competitors. Expleo Solutions's current 1-Year Sharpe Ratio is -1.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Expleo Solutions stock overvalued right now?
Based on GuruFocus' analysis, Expleo Solutions (NSE:EXPLEOSOL) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹1,289.11, compared to a current price of ₹792.40 — trading 38.5% below its estimated fair value. The current 1-Year Sharpe Ratio is -1.03. Expleo Solutions' overall GF Score™ is 87/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For Expleo Solutions (NSE:EXPLEOSOL), the current 1-Year Sharpe Ratio is -1.03 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Expleo Solutions (NSE:EXPLEOSOL) Overvalued in 2026?

Based on GuruFocus' analysis, Expleo Solutions stock appears to be undervalued. The current stock price of ₹792.40 is trading 38.5% below its estimated GF Value™ of ₹1,289.11. GuruFocus considers Expleo Solutions to be Significantly Undervalued.

Key valuation signals for NSE:EXPLEOSOL:

  • 1-Year Sharpe Ratio: -1.03
  • GF Value™: ₹1,289.11 vs. price of ₹792.40 (38.5% below fair value)
  • GF Score™: 87/100 with 3 warning signs

No single metric tells the full story. See the NSE:EXPLEOSOL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Expleo Solutions Business Description

Other Exchanges 533121:India
Address 6A, Sixth Floor, Prince Infocity II, Number 283/3 and 283/4, Rajiv Gandhi Salai (OMR), Kandanchavadi, Chennai, TN, IND, 600096
Expleo Solutions Ltd is an India-based holding company. It is engaged in providing software testing services. The company delivers software validation and verification services to the banking and financial services industry around the world. It offers its services to various industries, including banking, finance, and insurance; energy and utilities; automotive and manufacturing; retail and logistics, and telecommunications. The services offered by the company consist of Management Consultancy, Quality Management, Technical Testing Services and Training services.
87GF Score

Get the complete analysis for NSE:EXPLEOSOL

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹792.40
Price
₹1,289.11
GF Value